Actively Recruiting
Improving Social Functioning in People With Substance Use and Mental Health Disorders Using VR
Led by Sykehuset Innlandet HF · Updated on 2026-01-23
102
Participants Needed
2
Research Sites
81 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
ROPVR, a multi-centre, pragmatic randomized controlled trial (RCT) aims to evaluate a VR-technology which has been developed within an exploratory study and a development study, which facilitates social functioning among persons with a substance use and mental health disorder. Investigators will test a VR-program versus treatment as usual among patients enrolled into a long-term addiction-treatment facility. The RCT aims to evaluate the effectiveness of VR training compared to treatment as usual in improving resilience, quality of life, practical and social functioning and social participation (from baseline to 6 months), and to evaluate the cost-effectiveness of VR training versus treatment as usual.
CONDITIONS
Official Title
Improving Social Functioning in People With Substance Use and Mental Health Disorders Using VR
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older receiving in-patient substance use disorder treatment in specialized addiction treatment units in South-East Norway
- Includes persons serving prison sentences during in-patient treatment according to the Execution of Sentences Act in Norway
- Ability to read, understand, and sign the Norwegian informed consent form
- Willing and able to attend VR training two times a week for 5 weeks
You will not qualify if you...
- Significant visual, auditory, or balance impairment or other diseases affecting safety during VR sessions, such as epilepsy
- Current clinically significant severe mental health disorder, like an acute episode of psychosis or active suicidal plans; stable psychotic disorders or other severe mental illness are allowed
- Severe travel sickness as a proxy for simulation sickness
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Innlandet Hospital Trust
Brumunddal, Norway, 2381
Actively Recruiting
2
Sykehuset Innlandet HF
Hamar, Norway
Actively Recruiting
Research Team
M
Marja Leonhardt, PhD
CONTACT
L
Lars Lien, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here